Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-46.87
Price to sales ratio
3.28

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2522
OPK
Opko Health, Inc. - Common Stock
1.23 USD-8.89%-17.45%-13.99%-8.89%928.76 M USD
2641
ACRS
Aclaris Therapeutics, Inc. - Common Stock
5.50 USD-1.43%+0.73%+24.15%+250.32%768.15 M USD
2823
FLGT
Fulgent Genetics, Inc. - Common Stock
20.42 USD-0.63%-4.98%+8.39%-13.58%579.94 M USD
2855
MYGN
Myriad Genetics, Inc. - Common Stock
5.86 USD+0.51%-3.78%+35.96%-29.14%553.47 M USD

Frequently asked questions about Castle Biosciences, Inc. - Common stock

What is the Castle Biosciences, Inc. - Common stock stock price today?

The current price of Castle Biosciences, Inc. - Common stock (CSTL) is 22.98. Over the past 24 hours, the stock has changed by -3.12%. Follow the CSTL chart for real-time price dynamics.

What is the stock ticker of Castle Biosciences, Inc. - Common stock?

Castle Biosciences, Inc. - Common stock trades under the ticker CSTL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Castle Biosciences, Inc. - Common stock stock going up?

CSTL has changed by -5.67% over the last week, +10.85% over the last month, and -6.64% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Castle Biosciences, Inc. - Common stock net income for the last quarter?

Castle Biosciences, Inc. - Common stock reported net income of -14.52 M for the last quarter. The previous quarter showed -2.33 M, which means net income changed by -522.73%.

How many employees does Castle Biosciences, Inc. - Common stock have?

As of the latest available data, Castle Biosciences, Inc. - Common stock has 942 employees. Workforce size can provide additional context about the company's scale and operations.

What is Castle Biosciences, Inc. - Common stock EBITDA?

Castle Biosciences, Inc. - Common stock EBITDA is -14.6 M, and its EBITDA margin is -17.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Castle Biosciences, Inc. - Common stock stock?

You can buy Castle Biosciences, Inc. - Common stock (CSTL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Castle Biosciences, Inc. - Common stock stock?

Investing in Castle Biosciences, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CSTL chart and related analysis on metatrader.com as part of your research.

News